Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women
Clinical trial NCT02940522 · COMPLETED
Trial details
- NCT number
- NCT02940522
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2016-12-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.